David Young - 05 Aug 2021 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
05 Aug 2021
Net transactions value
$0
Form type
4
Filing time
09 Aug 2021, 16:33:44 UTC
Previous filing
09 Jul 2021
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Award +7,601 +2% 381,964 05 Aug 2021 Direct F1
holding PCSA Common Stock 573,568 05 Aug 2021 By Young-Plaisance Revocable Trust
holding PCSA Common Stock 694,591 05 Aug 2021 By Family Entities
holding PCSA Common Stock 37,504 05 Aug 2021 By CorLyst, LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.